ℹ️ Observational Association Only Evidence
Home blood pressure telemonitoring as a strategy for improving cardiovascular outcomes has shown promise in smaller trials, but real-world data at scale remain limited. This Scottish registry study examined 9,500 telemonitoring users against a backdrop of nearly 450,000 hypertensive patients, with follow-up through 2022.
Patient Counseling Points
- Patients using the Connect Me BP telemonitoring system achieved blood pressure reductions within 3 months, with improvements sustained at 1 year
- Telemonitoring users experienced significantly lower rates of cardiovascular events, hospitalizations, and death compared with standard care patients in adjusted analyses
- Patients who enrolled in telemonitoring tended to be younger, on fewer antihypertensives, and from less deprived areas — meaningful selection differences that limit generalizability to higher-risk populations
- The study cannot establish that telemonitoring caused outcome improvements; unmeasured confounders and voluntary enrollment bias are acknowledged limitations
Patient Care Applications
- Recognize home telemonitoring as a reasonable adjunct for engaged hypertensive patients, particularly those with difficult-to-control blood pressure or prior cardiovascular risk
- Reassure patients that validated home devices used consistently add clinical value beyond single office readings
- Redirect patients from consumer-framed expectations of definitive protection; observational data does not confirm that monitoring itself prevents events
- Interpret current evidence as hypothesis-generating pending prospective trials in higher-risk and socioeconomically diverse populations
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS